Table 2 Comparative efficacy of treatments for ORR in network meta-analysis.

From: Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis

Chemotherapy

2.32 (1.83, 3)

3.9 (2.78, 5.39)

0.43 (0.33, 0.55)

ICI

1.67 (1.11, 2.5)

0.26 (0.19, 0.36)

0.6 (0.4, 0.9)

ICI-chemo

  1. ICI immune checkpoint inhibitors, ICI-chemo ICI-combined chemotherapy.
Back to article page